Diabetes Mellitus, Type 2

• Novo Nordisk Investigational Site — Alexander City, Alabama, United States
• Novo Nordisk Investigational Site — Birmingham, Alabama, United States
• Novo Nordisk Investigational Site — Encino, California, United States
• Novo Nordisk Investigational Site — Fullerton, California, United States

• Advanced Clinical Res Inst — Anaheim, California, United States
• Torrance Clinical Research — Lomita, California, United States
• Elite Research Institute — Miami, Florida, United States
• Compass Research, Llc — Orlando, Florida, United States

• Novo Nordisk Investigational Site — Tokyo, Japan

• Johns Hopkins University — Baltimore, Maryland, United States

• Novo Nordisk Investigational Site — Phoenix, Arizona, United States
• Novo Nordisk Investigational Site — Anaheim, California, United States
• Novo Nordisk Investigational Site — Fresno, California, United States
• Novo Nordisk Investigational Site — Los Angeles, California, United States

• Novo Nordisk Investigational Site — Rochester, Minnesota, United States

• Novo Nordisk Investigational Site — Birmingham, Alabama, United States
• Novo Nordisk Investigational Site — Escondido, California, United States
• Novo Nordisk Investigational Site — Fresno, California, United States
• Novo Nordisk Investigational Site — Huntington Beach, California, United States

• Novo Nordisk Investigational Site — Beijing, Beijing Municipality, China
• Novo Nordisk Investigational Site — Beijing, Beijing Municipality, China
• Novo Nordisk Investigational Site — Chongqing, Chongqing Municipality, China
• Novo Nordisk Investigational Site — Fuzhou, Fujian, China

• St. Joseph's Primary Care Diabetes Support Program — London, Ontario, Canada

Not specified